Targeted RNA sequencing is being hailed as a major growth area up to 2024.

RNAseq has become indispensable analytical tool and is hotly expected expected that new RNAseq applications will be developed by the growing next-generation sequencing users community to support transcriptome oriented studies, notes Military Technologies

Regionally, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America followed by Europe dominates the global targeted RNA sequencing market, due to rising government support towards research and development. Asia is expected to witness high growth targeted RNA sequencing due to rising investment in India and China on research and development.

RNA sequencing (RNAseq) is a common tool for measuring relative gene expression levels. It is a versatile method that can be utilized to detect and characterize gene expression, mutations, gene fusions, and noncoding RNAs. Targeted RNA sequencing is a highly accurate method for selecting and sequencing specific transcripts of interest that offer both quantitative and qualitative information. Targeted RNA sequencing is a sequencing-based gene expression profiling method that allows quantification of messenger RNA (mRNA) or targeted non-coding RNA (ncRNA) levels for up to 300 customer-defined genes in a single amplification reaction. The ability to target a portion of the genome has revolutionized next-generation sequencing experiments. The analysis of exomes has exploded, custom panels for exome-style pull-down are being used to great effect for analyzing several thousand samples, and amplicon analysis is making it possible to run these samples in a single experiment.

Deciphering the role of both coding and non coding RNA is a critical area of science and David Smith of the Mayo Clinic wrote a piece for the FLG Magazine exploring the role of many RNA types in the understanding and treatment of cancer

Non-Coding RNA and Cancer

Building a full picture that links the continuum from DNA through RNA protein and into phenotypic descriptions is a promised land of molecular medicine and will surely give us untold new insights in to 2018 and the coming years.

More on these topics